Vanguard Group
AGL icon

Vanguard Group’s Agilon Health AGL Stock Holding History

Vanguard Group’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$12.6M Sell
732,872
-238,832
-25% -$4.63M ﹤0.01% 2848
2025
Q3 		$25M Sell
971,704
-240,257
-20% -$9.08M ﹤0.01% 2515
2025
Q2 		$69.7M Buy
1,211,961
+531
+0% +$42.6K ﹤0.01% 1977
2025
Q1 		$131M Sell
1,211,430
-33,066
-3% -$2.88M ﹤0.01% 1676
2024
Q4 		$59.1M Buy
1,244,496
+10,911
+0.9% +$660K ﹤0.01% 2100
2024
Q3 		$121M Buy
1,233,585
+6,288
+0.5% +$812K ﹤0.01% 1784
2024
Q2 		$201M Buy
1,227,297
+69,385
+6% +$9.88M ﹤0.01% 1492
2024
Q1 		$177M Buy
1,157,912
+14,862
+1% +$2.47M ﹤0.01% 1592
2023
Q4 		$359M Buy
1,143,050
+8,839
+0.8% +$3.2M 0.01% 1177
2023
Q3 		$504M Buy
1,134,211
+4,459
+0.4% +$2.01M 0.01% 895
2023
Q2 		$490M Buy
1,129,752
+360,302
+47% +$202M 0.01% 935
2023
Q1 		$457M Sell
769,450
-446
-0.1% -$250K 0.01% 958
2022
Q4 		$311M Buy
769,896
+19,074
+3% +$8.95M 0.01% 1154
2022
Q3 		$440M Buy
750,822
+96,284
+15% +$57.7M 0.01% 900
2022
Q2 		$357M Buy
654,538
+125,114
+24% +$63.3M 0.01% 1063
2022
Q1 		$336M Buy
529,424
+7,090
+1% +$3.65M 0.01% 1229
2021
Q4 		$353M Buy
522,334
+277,091
+113% +$169M 0.01% 1231
2021
Q3 		$161M Buy
245,243
+54,108
+28% +$46.2M ﹤0.01% 1727
2021
Q2 		$194M Buy
+191,135
New +$167M ﹤0.01% 1646

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group's AGL Position: Q4 2025 in Review

Vanguard Group reduced its Agilon Health (AGL) stake by 25% in Q4 2025, selling an estimated $4.63M and leaving 732,872 shares worth $12.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2848.

Vanguard Group first reported a position in AGL in Q2 2021 and has held it in 19 quarters since. The position peaked at $504M in Q3 2023. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Vanguard Group held 732,872 shares of Agilon Health worth $12.6M as of Q4 2025.
  • Vanguard Group sold 238,832 Agilon Health shares in Q4 2025, an estimated $4.63M.
  • Agilon Health made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2848 holding.
  • Vanguard Group first reported a position in Agilon Health in Q2 2021 and has held it in 19 quarters since.
  • Vanguard Group's Agilon Health position peaked at $504M in Q3 2023.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.